首页|恩格列净片与格列奇特缓释片联用治疗对2型糖尿病患者血糖指标及不良反应情况的影响

恩格列净片与格列奇特缓释片联用治疗对2型糖尿病患者血糖指标及不良反应情况的影响

Effects of Combination of Empagliflozin Tablet and Gliclazide Sustained-release Tablet on Blood Glucose Indexes and Adverse Reactions in Patients with Type 2 Diabetes

扫码查看
目的 探讨恩格列净片与格列奇特缓释片联用治疗对2型糖尿病患者血糖指标及不良反应情况的影响.方法 选取2023年1-12月厦门市第三医院收治的70例2型糖尿病患者为研究对象,随机数表法分为两组,各35例.对照组以恩格列净片治疗,观察组以恩格列净片与格列奇特缓释片联合治疗,分析两组临床数据.结果 观察组治疗后空腹血糖、餐后2 h血糖与糖化血红蛋白水平低于对照组,差异有统计学意义(P均<0.05);观察组治疗后低密度脂蛋白胆固醇、总胆固醇、三酰甘油水平低于对照组,高密度脂蛋白胆固醇高于对照组,差异有统计学意义(P均<0.05);观察组治疗后空腹胰岛素、胰岛素抵抗指数低于对照组,胰岛β细胞功能指数高于对照组,差异有统计学意义(P均<0.05);两组不良反应总发生率对比,差异无统计学意义(P>0.05).结论 恩格列净片与格列奇特缓释片联用治疗可使2型糖尿病患者血糖血脂水平得到更为有效的控制,改善患者胰岛β细胞功能,且不会明显增加不良反应.
Objective To investigate the effects of combined treatment of empagliflozin tablet and gliclazide sustained-release tablet on blood glucose indexes and adverse reactions in patients with type 2 diabetes.Methods A total of seventy patients with type 2 diabetes admitted to Xiamen Third Hospital from January to December 2023 were selected as the study objects and divided into two groups by random number table method,with thirty-five patients in each group.The control group was treated with empagliflozin tablets,and the observation group was treated with empa-gliflozin tablets combined with gliclazide sustained-release tablets.The clinical data of two groups were analyzed.Results The levels of fasting blood glucose,2 h postprandial blood glucose and glycosylated hemoglobin A1c in obser-vation group after treatment were lower than those in control group,the differences were statistically significant(all P<0.05).After treatment,the levels of low density lipoprotein cholesterol,total cholesterol and triacylglycerol in observa-tion group were lower than those in control group,and the level of high density lipoprotein cholesterol was higher than that of control group,the differences were statistically significant(all P<0.05).After treatment,fasting insulin and in-sulin resistance index in observation group were lower than those in control group,and islet β cell function index was higher than those in control group,the differences were statistically significant(all P<0.05).The total incidence of ad-verse reactions in two groups was compared,the difference was not statistically significant(P>0.05).Conclusion The combination of empagliflozin tablets and gliclazide sustained-release tablets can effectively control blood glucose and lipid levels in patients with type 2 diabetes,improve the function of pancreatic β cells,and do not significantly in-crease the adverse reactions.

Type 2 diabetesEmpagliflozin tabletsGliclazide sustained-release tabletsBlood blucose levelsIslet beta cellsAdverse reaction

柯燕妮、薛燕琴、林蔚

展开 >

厦门大学附属第一医院同安院区(厦门市第三医院)药学部,福建厦门 361100

2型糖尿病 恩格列净片 格列奇特缓释片 血糖水平 胰岛β细胞 不良反应

2024

糖尿病新世界
中国病理生理学会

糖尿病新世界

影响因子:0.461
ISSN:1672-4062
年,卷(期):2024.27(6)
  • 16